Q1 FY27 results: revenue up 130 percent YoY, PAT jumps to Rs 169.41 lakh

Revenue Growth 20pctPat Growth 25pctResults View source PDF Explain this filing

ARVEE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.0%Reaction day

₹156.70

prior close

₹156.52

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-1.0% vs market

Specialty Chemicals peers, median of 95sector-0.0%-1.0% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 1.0 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+4.1

10m

+0.1

15m

+0.1

30m

+2.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.0-0.1-1.0-0.0-1.0

Next day

+12.9-0.2+13.1+0.1+12.8

+12.4+0.1+12.2+0.4+12.0

+5.4+0.3+5.1+0.5+4.9

+5.3+0.4+4.9+0.6+4.7

+5.7+0.5+5.2-0.4+6.1

+9.3+0.3+9.0-0.6+9.9

15d

+6.4+1.9+4.6+1.3+5.1

+24.1+2.2+22.0+1.7+22.4

+29.5-1.2+30.6-1.2+30.7

—————

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 95Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Revenue from operations rose to Rs 1,722.53 lakh in Q1 FY27 versus Rs 748 lakh in Q1 FY26, a 130 percent jump. Profit after tax surged to Rs 169.41 lakh from Rs 16.91 lakh. EPS at Rs 1.54 versus Rs 0.15. Board also postponed Scheme of Arrangement, and approved Directors Report and AGM notice.

Likely market impact

Strong revenue and profit growth signals improving business momentum, though scheme of arrangement deferred.